We've published the latest Rapid Action Drug Alerts and Response (RADAR) report, which presents changes on drug trends, harms and use of services in Scotland to inform immediate and short-term actions that reduce drug harms. View the full report 🔽 publichealthscotland.scot/RADAR

Lived experience roles are a key part of a recovery-focused mental health system. We’ve some catching up to do in Scotland but the people we work with across the country are a collective voice for change in the make up of our mental health workforce. #PeerLeadership lnkd.in/p/eTyKucPe

New paper out! 📢 Our systematic review examined school-age outcomes following prenatal opioid exposure, bringing together evidence from 27 studies involving more than 31,000 exposed children. [1/3] onlinelibrary.wiley.com/doi/10.1111/... @uofgshw.bsky.social @dundee.ac.uk @morayhouse.bsky.social

📣 Evidence brief is now published! 💭 Ketamine Trends in Scotland: Analysis of Police Seizure Data and Review of Early Identification Methods 👥 By Kristin Ceniccola-Campos, Laura Murphy, and Felicity Carlysle-Davies 📰 Read the full report here: buff.ly/gnucCYF

📣 Our mapping tool has been updated! Thanks to University of Edinburgh student Amelia Duane our mapping tool has been updated up to 2026. Check it out here, and follow the link to upload any additional research you would like to contribute. drns.ac.uk/research-map...

📣 We held a webinar on 5 May 2026, presented by Prof Michael Eddleston on the RUFUS study and its exploration of flumazenil as a potential treatment for suspected benzodiazepine overdose in emergency settings. 📹️ Watch the full webinar here: buff.ly/C4fGqPF

The RUFUS Trial: Could the Benzodiazepine Antidote Flumazenil be used Safely and Effectively Pre-hospital? - Drug Research Network Scotland

The Drugs Research Network Scotland (DRNS) held a webinar on the 5th of May 2026, “The RUFUS Trial: Could the Benzodiazepine Antidote Flumazenil be used Safely and Effectively…

drns.ac.uk

📣 Our next webinar is less than a week away! Sign up below⬇️ The RUFUS Trial: Could the Benzodiazepine Antidote Flumazenil be used Safely and Effectively Pre-hospital? 📅 5 May 2026 🕚️ 11:00 AM - 12:00 PM 📍 Online via Teams 🎟️ Register here: buff.ly/5O2qCLH

📣 Our next webinar is a couple weeks away! The RUFUS Trial: Could the Benzodiazepine Antidote Flumazenil be used Safely and Effectively Pre-hospital? 📅 5 May 2026 🕚️ 11:00 AM - 12:00 PM 📍 Online via Teams 🎟️ Register here: buff.ly/5O2qCLH

The @nrs-mh.bsky.social Annual Scientific Meeting will return Thursday 22 October, at the Royal College of Physicians in Edinburgh. Save the date 🔗 https://www.nhsresearchscotland.org.uk/calendar/nhs-research-scotland-mental-health-annual-scientific-meeting-2026

We've published the latest Rapid Action Drug Alerts and Response (RADAR) report, which presents changes on drug trends, harms and use of services in Scotland to inform immediate and short-term actions that reduce drug harms. View the full report: https://ow.ly/f4HY50YQXUQ

📣 Our next webinar is a couple weeks away! The RUFUS Trial: Could the Benzodiazepine Antidote Flumazenil be used Safely and Effectively Pre-hospital? 📅 5 May 2026 🕚️ 11:00 AM - 12:00 PM 📍 Online via Teams 🎟️ Register here: buff.ly/5O2qCLH

📣 New blog post!✍️ 🗣️ The Ceasefire is Over: Documentation of a Mass Overdose Event on Vancouver’s Downtown Eastside (DTES) by Graeme Strachan 💻️ Read the full blog here: buff.ly/hdzBHod

📢 New funding opportunity The Office for Life Sciences has launched the £20m Addiction Healthcare Goals - Catalysing Innovation Awards, delivered by Innovate UK. This programme aims to fast-track new solutions to tackle drug and alcohol addiction challenges. ➡️Read more and apply: buff.ly/JrP85id

Programmes - Innovate UK Business Connect

We offer a variety of innovation programmes to support businesses and researchers in developing and commercialising new products, processes, and services. These programmes can include related funding…

buff.ly

📣 New Webinar! The RUFUS Trial: Could the Benzodiazepine Antidote Flumazenil be used Safely and Effectively Pre-hospital? 📅 5 May 2026 🕚️ 11:00 AM - 12:00 PM 📍 Online via Teams 🎟️ Register here: buff.ly/5O2qCLH

📣 New blog post! 👥 Meeting People Where They Are: Reflections from the RCGP Addiction Conference by Sophie Given 📰 Read the blog post here: buff.ly/Cr4P9xG

📰 New blog post! ✨️ Adventures in Addiction Science: Insights and Innovations from the SSA PhD Symposium and Conference 2025 by Kristina Hnízdilová 💻️ Read the blog here: buff.ly/MNpHZm7

📣 ABSTRACT SUBMISSION CLOSING TOMORROW 📅 Submit to admin@drns.ac.uk by 13th March 2026 ✨ Details here: buff.ly/MU6ICru 👥 Annual Conference 2026: Developments in Harm Reduction 📅 4 June 2026 📍 Glasgow Caledonian University 🎟️ WAITLIST: buff.ly/87E4KPf

buff.ly

📹 Missed our webinar? The recording is now online! 🔬 On 4 March, Dr. Richard Lowrie from the Centre for Homelessness and Inclusion Health discussed reducing overdose and drug deaths in people facing homelessness and other disadvantages. 🎥 Watch the recording here: buff.ly/n6fzyU7

Reducing Overdose and Drug Deaths in People Facing Homelessness and Other Disadvantages Webinar

Recording of the webinar in collaboration with the Dr Richard Lowrie from the Centre for Homelessness and Inclusion Health. Reducing overdose and drug deaths in people facing homelessness and other…

youtube.com

📣 ABSTRACT SUBMISSION DEADLINE EXTENDED 📅 Submit to admin@drns.ac.uk by 13th March 2026 ✨ Details here: buff.ly/MU6ICru 👥 Annual Conference 2026: Developments in Harm Reduction 📅 4 June 2026 📍 Glasgow Caledonian University 🎟️ WAITLIST: buff.ly/87E4KPf

If you would like to share your research or shape discussions about addiction science, please consider submitting an application for an oral presentation, poster presentation, or workshop at the 2026 Annual Conference tinyurl.com/32y28hzk

📣 Call for abstracts closing in 1 week! Deadline: 7 March 2026 Details here: buff.ly/7G2IiiU ✨ Annual Conference 2026: Developments in Harm Reduction 📅 4 June 2026 📍 Glasgow Caledonian University 🗣️ keynotes from Dr Chelsea Shover & Prof Catherine Comiskey 🎟️ WAITLIST: buff.ly/87E4KPf

Funding Opportunity: Advancing Innovation in Drug & Alcohol Addiction Healthcare Innovate UK through the Office for Life Sciences Addiction Healthcare Goals programme with up to £20m available across two competitions Closing: 6 May 2026 (11:00am UK time) Learn more: www.ukri.org/opportunity/...

Advancing innovation in drug and alcohol addiction healthcare

Organisations can apply for a share of £20 million across two competitions. Projects will advance development of pharmaceutical, digital and MedTech tools to improve treatment recovery and prevention ...

ukri.org

New fully funded PhD based at @dundee.ac.uk , supervised by Dr Harry Hebert, Prof Lesley Colvin and myself, to investigate Opioid, Gabapentinoid and Antidepressant co‑prescribing. Apply here: www.findaphd.com/phds/project... or get in touch if you would like to find out more!

Trends and characteristics of Opioid, Gabapentinoid and Antidepressant co-prescribing (TOGA) at University of Dundee on FindAPhD.com

PhD Project - Trends and characteristics of Opioid, Gabapentinoid and Antidepressant co-prescribing (TOGA) at University of Dundee, listed on FindAPhD.com

findaphd.com

New paper on "Impact of Scotland's first Virtual Consumption app". Thanks @catrionamath.bsky.social @hadidf.bsky.social for support and guidance. Thanks @sheffielduni.bsky.social for Open Access publishing. @profalexstevens.bsky.social for continuing supervision and support. doi.org/10.1186/s129...

Accessing digital harm reduction services —exploring the impact of the “Here4UScotland” application - Harm Reduction Journal

Background The unique challenges faced by vulnerable drug users highlight the urgent need for accessible, immediate digital interventions which people can access anywhere and at any time. This study e...

doi.org

PLEASE SHARE: 🚨 Two Fully Funded PhD Opportunities – @glasgow.ac.uk @uofgshw.bsky.social 🚨 We’re recruiting for two PhD studentships exploring child and adolescent outcomes following prenatal opioid exposure, working with leading researchers and unique UK-wide administrative datasets 1/4

📣 2 WEEKS AWAY Reducing Overdose and Drug Deaths in People Facing Homelessness and Other Disadvantages 👥 in collaboration with the Centre for Homelessness and Inclusion Health 📅 4 March 2026 🕘 11:00 - 12:00 📍 Online via Teams Registration: buff.ly/ZKE44Ni

Reducing Overdose and Drug Deaths in People Facing Homelessness

in collaboration with the Centre for Homelessness and Inclusion Health

buff.ly

📣 NEW EVENT✨ Reducing Overdose and Drug Deaths in People Facing Homelessness and Other Disadvantages 👥 in collaboration with the Centre for Homelessness and Inclusion Health 📅 4 March 2026 🕘 11:00 - 12:00 📍 Online via Teams Registration: buff.ly/ZKE44Ni

📣 NEW BLOG POST ✨ Helping people to live and survive co-use of benzodiazepines/z-drugs and opioids: the importance of asking how and why people co-use 👥 by Gabriele Vojt, Joanna Kesten, Jennifer Scott, Hannah Family, on behalf of the Benzo Opioid study team Click here to read: buff.ly/17rVOoY

✨ Annual Conference 2026: Developments in Harm Reduction 📅 4th June 2026 📍 Glasgow Caledonian University 🗣️ with keynotes from Dr Chelsea Shover & Prof Catherine Comiskey 🎟️ REGISTRATION: buff.ly/87E4KPf 📣 Call for abstracts NOW OPEN, full details here: buff.ly/bZYg5PA Deadline: 7th March 2026